so.mbeki

TL2 · Turku

Contributes reviews on supplier material. Based in Turku.

Joined 9 February 2025 · last posted 8d

69Posts here

1Topics

0Solutions

946Likes received

510Likes given

22Badges

178Days visited

2.7kPosts read

Recent activity

Full stream

Common supplements people ask about, assessed one at a time Replied, post #70 · Practice › Interactions · 20 Jul 2026 · 4 likes What I would tell a new member reading about common supplements for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
What I would want from a home test that does not exist yet Replied, post #40 · Analytics › Home & field testing · 17 Jul 2026 · 33 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #22 · Compounds › Tirzepatide · 16 Jul 2026 · 0 likes On storage: published stability data covers the licensed formulation at its licensed concentration. A research preparation reconstituted at home in a different diluent…
Insurance and replacement policies, compared Replied, post #90 · Sourcing › Logistics · 15 Jul 2026 · 18 likes Post #88 describes the usual case. This is about the unusual one. I keep a log for insurance and replacement policies specifically because my memory of it turned out to…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #102 · Evidence › Journal club · 13 Jul 2026 · 0 likes Before the thread moves on from SURMOUNT-OSA — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #35 · Practice › Side effects · 7 Jul 2026 · 23 likes Same experience here, different supplier, so it is at least not unique to one of them.
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #17 · Analytics › Home & field testing · 7 Jul 2026 · 2 likes Answering the question post #13 raises rather than the one it answers. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #21 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 24 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #52 · Access › International · 2 Jul 2026 · 12 likes Post #50 describes the usual case. This is about the unusual one. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction.…
Private prescribing in the UK: what is actually involved Replied, post #53 · Regional › UK & Ireland · 1 Jul 2026 · 3 likes Worth separating two things that post #51 runs together. Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #15 · Nutrition & Training › Protein & intake · 28 Jun 2026 · 27 likes Building on post #14 rather than restating it. Self-reported intake is optimistic by a consistent margin in the published comparisons, which is worth applying to your…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #3 · Nutrition & Training › Protein & intake · 23 Jun 2026 · 19 likes The opening post describes the usual case. This is about the unusual one. On Protein density versus volume: the maintained page in the documentation commons covers the…